Cardiology Department, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham General Hospital, Cheltenham, United Kingdom.
Institute of Cardiovascular Sciences, University College of London, London, United Kingdom; Department of Cardiology, Barts Health NHS Trust, London, United Kingdom.
Hellenic J Cardiol. 2017 May-Jun;58(3):178-189. doi: 10.1016/j.hjc.2017.01.028. Epub 2017 Feb 16.
Patients with diabetes mellitus are at increased risk of developing coronary artery disease (CAD) and have an increased incidence of recurrent events following revascularization. Choosing the most appropriate strategy to revascularize these high-risk patients is crucial for improving the clinical outcomes. Several studies, randomized trials and meta-analyses have compared short- and long-term outcomes following coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in diabetic patients suffering from CAD. The aim of this article is to review the currently available evidence on the role of PCI and CABG in the management of diabetic patients with CAD.
糖尿病患者发生冠状动脉疾病 (CAD) 的风险增加，并且在血运重建后复发事件的发生率增加。为了改善临床结局，选择最适合这些高危患者的血运重建策略至关重要。多项研究、随机试验和荟萃分析比较了糖尿病合并 CAD 患者行冠状动脉旁路移植术 (CABG) 和经皮冠状动脉介入治疗 (PCI) 的短期和长期结局。本文旨在回顾目前关于 PCI 和 CABG 在糖尿病合并 CAD 患者管理中的作用的证据。
